A Buffalo life science firm has signed a $4.7 million, five-year contract to expand its cloud-based simulation software to help fight neglected diseases around the world. Cognigen Corp., a division of Simulations Plus Inc. (NASDAQ: SLP) near Los Angeles, is working with an international foundation to help researchers around the world connect and share best practices. Ultimately, the goal is to reduce the risks and cost of drug development and speed the delivery of new life-saving medicines. The...